Histopathological analysis of vesicular and bullous lesions in Kaposi sarcoma.
BACKGROUND
In this study, the clinical and morphological features of vesiculobullous lesions observed in Kaposi sarcoma are analyzed, and the features of bullous Kaposi sarcoma cases are emphasized.


METHODS
A total of 178 biopsy materials of 75 cases diagnosed as classic-type cutaneous Kaposi sarcoma were reviewed. Twenty-five cases showing vesiculobullous features were included in the study. Tumor, epidermis, dermis, and clinical data regarding these cases was evaluated.


RESULTS
Vesicular changes were observed in 21 (12%) out of 178 lesions of the 75 cases, while bullous changes were present in only 4 (2%). In all cases where vesicular and bullous changes were detected, tumor, epidermis, and dermis changes were similar. All cases were nodular stage KS lesions, whereas hyperkeratosis and serum exudation in the epidermis, marked edema in the dermis, and enlarged lymphatic vessels and chronic inflammatory response were observed.


CONCLUSIONS
Our findings suggest that changes in vascular resistance occurring during tumor progression are the most important factors comprising vesiculobullous morphology.
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1646397188748474.
Department of Pathology, Karaelmas University, Faculty of Medicine, Zonguldak, Turkey. niluferkandemir@yahoo.com
Nilüfer Onak
NO
Kandemir
Figen
F
Barut
Banu Doğan
BD
Gün
Nilgün Solak
NS
Tekin
Sevinç Hallaç
SH
Keser
Sükrü Oğuz
SO
Ozdamar
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy; D001768:Blister / Q000473:pathology; D020405:Dermis / Q000737:chemistry / Q000473:pathology*; D018450:Disease Progression; D004817:Epidermis / Q000737:chemistry / Q000473:pathology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D042601:Lymphatic Vessels / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012514:Sarcoma, Kaposi / Q000737:chemistry / Q000473:pathology*; D012872:Skin Diseases, Vesiculobullous / Q000473:pathology*; D012878:Skin Neoplasms / Q000737:chemistry / Q000473:pathology*
D014408:Biomarkers, Tumor